Dennis Cho, Senior Vice President, Chief Legal Officer and Corporate Secretary of Twist Bioscience Corp, filed a statement of changes in beneficial ownership on August 21, 2026, reporting a sale of common stock executed on August 19, 2026.

Key Highlights

  • Shares sold: Dennis Cho disposed of 14,205 shares of Twist Bioscience Corp common stock on August 19, 2026.
  • Sale price: The shares were sold at $129.75 each, according to the filing.
  • Remaining ownership: Following the transaction, Cho directly holds 75,661 shares of common stock.
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by Cho on February 17, 2026.
  • Reporting person role: Cho serves as Senior Vice President, Chief Legal Officer and Corporate Secretary of Twist Bioscience Corp.

Dennis Cho's Share Sale at Twist Bioscience Corp

According to the filing, Dennis Cho, an officer of Twist Bioscience Corp (NASDAQ:TWST), disposed of 14,205 shares of the company's common stock on August 19, 2026, at a price of $129.75 per share. The transaction was coded "S," indicating a sale of non-derivative securities. The filing notes that the sale was direct in form of ownership.

Twist Bioscience Corp is a synthetic biology company. The filing discloses that following this transaction, Cho directly beneficially owns 75,661 shares of common stock. The sale was executed under a Rule 10b5-1 trading plan that Cho had previously adopted on February 17, 2026, as noted in the explanation of responses included in the filing. The form was signed on August 21, 2026, by Kendra Fox as Attorney-in-Fact for Dennis Cho. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing reported a single open-market sale of 14,205 shares of Twist Bioscience Corp common stock by officer Dennis Cho at $129.75 per share on August 19, 2026, conducted under a pre-established Rule 10b5-1 trading plan, leaving Cho with 75,661 directly held shares.